Brought to you by:
Atherectomy in PAD: Meta-analysis of ‘extensive’ published literature supports use in ‘appropriately selected’ patients
A systematic review and meta-analysis of more than 300 original investigations on atherectomy in peripheral arterial disease (PAD) highlights “overall favorable” clinical outcomes. This and other findings from what researchers say is the first investigation to provide a “comprehensive” overview…
First patient enrolled in AngioDynamics’ AMBITION BTK trial for CLTI
AngioDynamics today announced enrollment of the first patient in AMBITION BTK, a randomized study of the Auryon atherectomy system in patients with below-the-knee chronic limb-threatening ischemia (CLTI). A press release details that AMBITION BTK is a prospective, multicenter, randomized controlled…
First patient enrolled in study of integrated laser atherectomy and IVL catheter
Royal Philips has announced enrolment of the first patient in the US THOR IDE clinical trial, which will study an innovative combined laser atherectomy and intravascular lithotripsy (IVL) catheter. Procedures that previously required the use of two different devices can…
Laser atherectomy redefined: Breakthrough 355nm technology opens next frontier in treatment
In this supplement, sponsored by AngioDynamics:
AngioDynamics announces CE mark approval in Europe for the Auryon system
AngioDynamics today announced European CE mark approval of the Auryon atherectomy system, designed for the treatment of peripheral arterial disease (PAD), including chronic limb-threatening ischaemia (CLTI) and in-stent restenosis (ISR). The Auryon atherectomy system uses solid-state laser technology to treat…
Vascular Specialist’s top stories of 2023
Which stories captured the attention of the vascular community over the course of the past year? Read our summary of the trending articles from across Vascular Specialist in 2023. Let us know your highlights by leaving a reply at the…
Society for Vascular Surgery addresses latest mainstream media reports on atherectomy
The Society for Vascular Surgery (SVS) has issued a statement addressing the latest reports published by ProPublica on atherectomy use in the U.S. The nonprofit investigative news outlet published three articles in its latest round of investigations looking into Medicare…
Patients with claudication receive more ‘aggressive’ surgical management in high-competition regions, study finds
Demonstrating the “susceptibility” of care delivery to regional market competition, M. Libby Weaver, MD, presented the case that intermittent claudication (IC) is a “novel and underdefined” driver of practice variation in management of patients at the 2023 Southern Association for…
The 10 most popular Vascular Specialist stories of November 2022
Among November’s most read Vascular Specialist stories were updates from the BEST-CLI trial in the form of new data and funding; a guest editorial calling for (better) training vis-à-vis counseling patients about their treatment options; news of positive results from…
‘Significant’ increase in atherectomy use in US largely driven by office-based procedures, VQI data show
In the United States, atherectomy use in peripheral vascular interventions (PVIs) “more than doubled” from 2010 to 2019, with office-based procedures a “major driver” of this increase. This is according to published U.S. data from the Vascular Quality Initiative (VQI),…